Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ)
CNY 13.37
(0.91%)
CNY 13.37
(0.91%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4.88 Billion CNY | 57.92% |
| 2022 | 3.09 Billion CNY | 6.4% |
| 2021 | 2.9 Billion CNY | 4742.14% |
| 2020 | 60.05 Million CNY | -87.56% |
| 2019 | 482.83 Million CNY | -39.56% |
| 2018 | 798.89 Million CNY | -10.89% |
| 2017 | 896.51 Million CNY | 12.78% |
| 2016 | 794.91 Million CNY | 27.19% |
| 2015 | 625 Million CNY | 0.0% |
| 2014 | - CNY | -100.0% |
| 2013 | 220 Million CNY | 41.03% |
| 2012 | 156 Million CNY | -21.42% |
| 2011 | 198.52 Million CNY | 10.15% |
| 2010 | 180.23 Million CNY | 62.67% |
| 2009 | 110.79 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 4.66 Billion CNY | -4.57% |
| 2024 Q3 | 3.19 Billion CNY | -60.75% |
| 2024 Q2 | 5.37 Billion CNY | 15.19% |
| 2023 Q3 | 3.12 Billion CNY | 0.46% |
| 2023 Q4 | 4.88 Billion CNY | 56.43% |
| 2023 Q1 | 3.1 Billion CNY | 0.42% |
| 2023 FY | 4.88 Billion CNY | 57.92% |
| 2023 Q2 | 3.1 Billion CNY | 0.07% |
| 2022 Q1 | 2.96 Billion CNY | 1.91% |
| 2022 FY | 3.09 Billion CNY | 6.4% |
| 2022 Q4 | 3.09 Billion CNY | 3.53% |
| 2022 Q3 | 2.98 Billion CNY | -0.42% |
| 2022 Q2 | 3 Billion CNY | 1.27% |
| 2021 Q4 | 2.9 Billion CNY | 14.56% |
| 2021 Q3 | 2.53 Billion CNY | 7.55% |
| 2021 FY | 2.9 Billion CNY | 4742.14% |
| 2021 Q1 | 2.19 Billion CNY | 3549.75% |
| 2021 Q2 | 2.36 Billion CNY | 7.68% |
| 2020 Q3 | 254.18 Million CNY | -57.96% |
| 2020 FY | 60.05 Million CNY | -87.56% |
| 2020 Q1 | 599.55 Million CNY | 24.17% |
| 2020 Q2 | 604.66 Million CNY | 0.85% |
| 2020 Q4 | 60.05 Million CNY | -76.37% |
| 2019 Q4 | 482.83 Million CNY | -45.73% |
| 2019 FY | 482.83 Million CNY | -39.56% |
| 2019 Q1 | 399.28 Million CNY | -50.02% |
| 2019 Q2 | 883.73 Million CNY | 121.33% |
| 2019 Q3 | 889.73 Million CNY | 0.68% |
| 2018 FY | 798.89 Million CNY | -10.89% |
| 2018 Q4 | 798.89 Million CNY | 0.07% |
| 2018 Q3 | 798.34 Million CNY | 0.08% |
| 2018 Q2 | 797.72 Million CNY | 0.08% |
| 2018 Q1 | 797.1 Million CNY | -11.09% |
| 2017 Q1 | 795.47 Million CNY | 0.07% |
| 2017 Q4 | 896.51 Million CNY | 0.06% |
| 2017 Q3 | 895.97 Million CNY | 12.55% |
| 2017 Q2 | 796.05 Million CNY | 0.07% |
| 2017 FY | 896.51 Million CNY | 12.78% |
| 2016 Q3 | 397.73 Million CNY | -1.11% |
| 2016 FY | 794.91 Million CNY | 27.19% |
| 2016 Q4 | 794.91 Million CNY | 99.86% |
| 2016 Q1 | 400 Million CNY | -36.0% |
| 2016 Q2 | 402.18 Million CNY | 0.55% |
| 2015 Q2 | 333 Million CNY | 122.0% |
| 2015 FY | 625 Million CNY | 0.0% |
| 2015 Q4 | 625 Million CNY | 46.03% |
| 2015 Q3 | 428 Million CNY | 28.53% |
| 2015 Q1 | 150 Million CNY | 0.0% |
| 2014 Q1 | 260 Million CNY | 18.18% |
| 2014 Q2 | 220 Million CNY | -15.38% |
| 2014 Q3 | - CNY | -100.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 FY | - CNY | -100.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 Q4 | 220 Million CNY | 0.0% |
| 2013 FY | 220 Million CNY | 41.03% |
| 2012 FY | 156 Million CNY | -21.42% |
| 2011 FY | 198.52 Million CNY | 10.15% |
| 2010 FY | 180.23 Million CNY | 62.67% |
| 2009 FY | 110.79 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 4.01 Billion CNY | -21.585% |
| ZJAMP Group Co., Ltd. | 2.88 Billion CNY | -69.228% |
| Luyan Pharma Co.,Ltd. | 4.84 Billion CNY | -0.946% |
| Ji Yao Holding Group Co., Ltd. | 1.44 Billion CNY | -237.328% |